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ABSTRACT
Background: Diabetes is a major health burden worldwide. There is a close association between albuminuria and
development of stroke in diabetics. This study was conducted to determine the frequency of albuminuria among
diabetic patients presenting with stroke
Methodology: This descriptive cross-sectional study was conducted in the department of Medicine, DHQ Teaching
Hospital, Abbottabad, from 15th April to 15th October, 2017. All diabetic patients of either gender above age 20 who
were admitted with stroke were included in the study on the basis on non-probability consecutive sampling. The data
was collected through a structured pro forma and analysed using SPSS-16.
Results: A total of 147 cases fulfilling the inclusion and exclusion criteria were enrolled, among them 93(63.27%)
were males and 54(36.73%) were females. Majority of the patients 54(36.73%) were between 41-50 years.
Frequency of albuminuria among diabetic patients presenting with stroke was 35.37%(n=52).
Conclusion: The frequency of albuminuria is high among diabetic patients presenting with stroke. It is recommended
that every diabetic patient should be routinely screened for albuminuria to prevent the disabling complication.
Key words: Diabetes mellitus, stroke, albuminuria.

INTRODUCTION: Diabetes is causing burden on all
health care systems around the world. It is estimated
that global prevalence of diabetes in 2010 was 6.4%,
affecting about 285 million adults, and will increase to
7.7% in 2030 affecting about 439 million adults.1
Prevalence of diabetes in Pakistan is 6 to 6.9% among
males and 2.5 to 3.5% in females in different areas.2

Endothelial cell dysfunction and inflammation are key
contributors to the development of stroke in diabetes
mellitus.5 As albuminuria is considered a sign of
endothelial
dysfunction,
and
sub-clinical
atherosclerosis, so presence of albuminuria is
considered an important predictor of stroke.6 Diabetic
nephropathy presenting as albuminuria is common in
diabetics (about 34%), thus highlighting the increased
risk of developing stroke.7

Diabetes causes several vascular complications in
patients categorized as macro and micro-vascular
disorders. Common macrovascular problems include
myocardial infarction, peripheral arterial diseases and
stroke, whereas microvascular problems result in
neuropathy, nephropathy and retinopathy.3 Prevalence
of cerebrovascular disease in diabetics is 7% having
2-3 times increased risk of fatal stroke as compared to
general population.4
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Close
association
between
albuminuria
and
macrovascular complication like stroke has been
reported in diabetic patients of Indian subcontinent.8
The incidence of stroke varies with the level of
albuminuria in diabetics. The higher urinary albumin
excretion is associated with increased risk of
developing stroke. The role of albuminuria as a
predictor of stroke in diabetics need further studies to
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strengthen this association.9

included in this study. There were 93 (63.27%) males
and 54(36.73%) females.

MATERIALS AND METHODS

Seventeen of the patients were between 20-30 years
(11.56%), while 19.73%(29) between 31-40 years,
36.73%(n=54)
between
41-50
years,
and
31.98%(n=47) between 51-60 years. The mean age
was 43.65+4.24 years.

This was a hospital based descriptive cross-sectional
study. 147 patients were included in the study that
were admitted in the Department of Medicine, DHQ
Teaching Hospital, Abbottabad, during the six months
period from 15th April to 15th October 2017 and were
diagnosed with stroke and were diabetic.

Frequency of albuminuria among diabetic patients
presenting with stroke was 35.37%(n=52) (Table 1).
59.62%(31) of these 52 patients were males and
40.38%(21) were females (Figure 1). Out of these 52
cases 4 (7.69%) were between 20-30 years,
11(21.15%) between 31-40 years, 23(44.23%)
between 41-50 years, and 14(26.93%) between
51-60 years of age. (Figure 2)

Sample size was calculated using the WHO software to
calculate the sample size taking confidence Level (1-α)
at 95%, absolute precision 10, frequency of
albuminuria in diabetic patients with stroke was kept as
42.1%.10 Sample Size (n) came out to be 147. The
sampling technique was nonprobability consecutive.
The patients were of age 20 and above and either
gender.
Prior approval from hospital ethical committee was
taken. Use of data for research and publication was
explained to the patients and/or their relatives, and
informed consent was taken.
All patients fulfilling the inclusion criteria that have their
diagnosis of stroke confirmed by neuroimaging (CT
Scan or MRI) were included in the study.
Detailed history from the patients was taken and a
complete physical examination was performed.
Laboratory tests such as FBC, LFTs, renal profile,
ultrasound abdomen and ECG was performed in all
patients, included in the study, 24 hour urine
collections was done by using a graduated standard jar
and sent after 24 completed hours to detect
albuminuria. The patients with previous history of
hypertension, smoking, valvular heart disease, atrial
fibrillation, chronic renal failure and cirrhosis found on
interview, physical examination or investigations were
excluded from the study.

patients

Yes

52

35.37

No

95

64.63

Total

147

100

No. of

Percentage

Table 1: Frequency of albuminuria among
diabetic patients presenting with stroke.

All the data was collected on a pre-designed proforma.
Data was entered and analysed using SPSS-16.
Continuous variables (e.g. age, 24 hours urinary
albumin excretion) were described in terms of Mean
and Standard Deviation. Frequencies and percentages
were calculated for categorical variables like gender
and Albuminuria. Albuminuria level was stratified
among age and gender to see the effect modifications.
All results were presented in the form of tables and
graphs. Appearance of >30mg of albumin measured
by 24 hour urinary protein in hospital laboratory was
considered significant.

primary care physicians of Pakistan in dealing with
Figure 1: Frequency of albuminuria among diabetic
patients presenting with stroke in age groups.
DISCUSSION
Diabetes mellitus is becoming a major contributor of
morbidity and mortality in Pakistan. World Health
Organization in its report shows that Pakistan has 5.2
million diabetic subjects, and the number is expected

RESULTS
A total of 147 diabetic patients with stroke were
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to increase to a staggering 13.9 million making it the
5th highest in the world by 2030.11

Other reported cerebrovascular clinical correlates with
microalbuminuria include cerebral ischemic lacunae,
middle cerebral artery stenosis, impaired carotid
arterial blood flow and vasomotor reactivity on Doppler
ultrasonography, and increased carotid artery
intima-media thickness. In addition, patients who have
had an acute stroke and have microalbuminuria have a
poorer
outcome
than
those
without
microalbuminuria.17

The recognition of frequency of microalbuminuria
among diabetics presenting with stroke in our society
was required so that we may timely manage the
disease course, set a regular follow up criteria and save
our patients from the morbidity.
Most of the patients in our study were between 41-50
years of age i.e. 36.73%. These figures are in
agreement with a study at Karachi with regards to
prevalence of type II diabetes mellitus and diabetic
retinopathy, which shows 58.32% of the patients
between 30-40 years and the mean age was recorded
as 42 years.12

Close
association
between
albuminuria
and
macrovascular complication like stroke has been
reported in diabetic patients of Indian subcontinent
also.8 The incidence of stroke varies with the level of
albuminuria in diabetics. The higher urinary albumin
excretion is associated with increased risk of
developing stroke.9

In our study, frequency of albuminuria among diabetic
patients presenting with stroke was 35.37%(n=52)
while 64.63%(n=95) had no findings of the morbidity,
these findings are in agreement with Nakamura T10
who recorded these figures as 42.1%.

CONCLUSION
The frequency of albuminuria is high among diabetic
patients presenting with stroke. Every patient who
present with stroke with diabetes, should be checked
out for albuminuria. It is also recommended that every
diabetic patient should be routinely screened for
albuminuria to prevent the disabling complication.

Agaba EI and coworkers investigated the prevalence of
microalbuminuria in newly diagnosed type 2 diabetic
patients and its clinical correlation and found
microalbuminuria
present in 32(49.2%) of the
patients, and was significantly associated with mean
arterial pressure, systemic hypertension and diabetic
retinopathy (P < 0.05). Microalbuminuria is common
in newly diagnosed patients with type 2 diabetes
mellitus and suggested that routine screening for
microalbuminuria as part of the initial evaluation of
these patients.13
Microalbuminuria is common among patients with
cerebrovascular disease and correlates with an
increased stroke risk even after correction for
confounding clinical risk factors. In the European
Prospective Investigation into Cancer in Norfolk
population, microalbuminuria was independently
associated with a 50% increased risk for stroke (hazard
ratio [HR] 1.49; 95% CI 1.13 to 2.14); the association
with macroalbuminuria was even greater (HR 2.43;
95% CI 1.11 to 6.26).14 In addition, a 15.5 year
cohort study that examined stroke risk factors in Japan
showed that urinary albumin was an independent risk
factor for stroke in men (RR 2.5; 95% CI 1.1 to 5.7)
but not in women.15
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